| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1318484 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SLC19A2 mRNA | CTD | PMID:20106945 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1318484 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SLC19A2 mRNA | CTD | PMID:20106945 PMID:21632981 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1318485 | 6480464 | Tetrachlorodibenzodioxin affects the expression of SLC19A2 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SLC19A2 mRNA | CTD | PMID:21215274 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1318484 | 6480464 | Tetrachlorodibenzodioxin affects the expression of SLC19A2 mRNA | CTD | PMID:22298810 |
| 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2,4-dinitrotoluene affects the expression of SLC19A2 mRNA | CTD | PMID:21346803 |
| 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2,6-dinitrotoluene affects the expression of SLC19A2 mRNA | CTD | PMID:21346803 |
| arsenite(3-) | affects expression | ISO | RGD:1318484 | 6480464 | arsenite affects the expression of SLC19A2 mRNA | CTD | PMID:22959463 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1318485 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in increased expression of SLC19A2 mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | increases expression | ISO | RGD:1318485 | 6480464 | Benzo(a)pyrene results in increased expression of SLC19A2 mRNA | CTD | PMID:21569818 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:1318484 | 6480464 | Benzo(a)pyrene results in increased expression of SLC19A2 mRNA | CTD | PMID:22316170 |
| benzo[a]pyrene | increases expression | ISO | RGD:1318485 | 6480464 | Benzo(a)pyrene results in increased expression of SLC19A2 mRNA | CTD | PMID:21569818 PMID:22228805 |
| benzo[a]pyrene | increases expression | ISO | RGD:1318484 | 6480464 | Benzo(a)pyrene results in increased expression of SLC19A2 mRNA | CTD | PMID:21632981 PMID:22316170 |
| benzo[a]pyrene | increases expression | ISO | RGD:1318485 | 6480464 | Benzo(a)pyrene results in increased expression of SLC19A2 mRNA | CTD | PMID:21569818 |
| benzo[a]pyrene | affects expression | ISO | RGD:1318484 | 6480464 | Benzo(a)pyrene affects the expression of SLC19A2 mRNA | CTD | PMID:20106945 |
| cadmium dichloride | increases expression | ISO | RGD:1318485 | 6480464 | Cadmium Chloride results in increased expression of SLC19A2 mRNA | CTD | PMID:20883709 |
| carmustine | decreases expression | EXP | | 6480464 | Carmustine results in decreased expression of SLC19A2 mRNA | CTD | PMID:16005536 |
| chloroprene | increases expression | ISO | RGD:1318485 | 6480464 | Chloroprene results in increased expression of SLC19A2 mRNA | CTD | PMID:23125180 |
| choline | multiple interactions | ISO | RGD:1318485 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of SLC19A2 mRNA | CTD | PMID:20938992 |
| copper(2+) sulfate | decreases expression | ISO | RGD:1318484 | 6480464 | Copper Sulfate results in decreased expression of SLC19A2 mRNA | CTD | PMID:19549813 |
| elemental selenium | decreases expression | ISO | RGD:1318484 | 6480464 | Selenium results in decreased expression of SLC19A2 mRNA | CTD | PMID:19244175 |
| folic acid | multiple interactions | ISO | RGD:1318485 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of SLC19A2 mRNA | CTD | PMID:20938992 |
| hydralazine | multiple interactions | ISO | RGD:1318484 | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of SLC19A2 mRNA | CTD | PMID:17183730 |
| indomethacin | increases expression | ISO | RGD:1318484 | 6480464 | Indomethacin results in increased expression of SLC19A2 mRNA | CTD | PMID:16984733 |
| L-methionine | multiple interactions | ISO | RGD:1318485 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of SLC19A2 mRNA | CTD | PMID:20938992 |
| leflunomide | increases expression | ISO | RGD:1318485 | 6480464 | leflunomide results in increased expression of SLC19A2 mRNA | CTD | PMID:19751817 |
| melphalan | increases expression | ISO | RGD:1318484 | 6480464 | Melphalan results in increased expression of SLC19A2 mRNA | CTD | PMID:22363485 |
| methotrexate | decreases expression | EXP | | 6480464 | Methotrexate results in decreased expression of SLC19A2 mRNA | CTD | PMID:16005536 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:1318484 | 6480464 | Acetylcysteine inhibits the reaction [elesclomol results in increased expression of SLC19A2 mRNA] | CTD | PMID:18723479 |
| N-nitrosodiethylamine | increases expression | ISO | RGD:1318485 | 6480464 | Diethylnitrosamine results in increased expression of SLC19A2 mRNA | CTD | PMID:17942915 |
| N-nitrosodiethylamine | decreases expression | EXP | | 6480464 | Diethylnitrosamine results in decreased expression of SLC19A2 mRNA | CTD | PMID:19638242 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of SLC19A2 mRNA; more ... | CTD | PMID:18164116 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:1318485 | 6480464 | MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of SLC19A2 mRNA] | CTD | PMID:17942915 |
| paracetamol | affects expression | ISO | RGD:1318485 | 6480464 | Acetaminophen affects the expression of SLC19A2 mRNA | CTD | PMID:17562736 |
| paracetamol | increases expression | ISO | RGD:1318484 | 6480464 | Acetaminophen results in increased expression of SLC19A2 mRNA | CTD | PMID:21420995 |
| phenobarbital | affects expression | ISO | RGD:1318484 | 6480464 | Phenobarbital affects the expression of SLC19A2 mRNA | CTD | PMID:19159669 |
| pirinixic acid | decreases expression | ISO | RGD:1318485 | 6480464 | pirinixic acid results in decreased expression of SLC19A2 mRNA | CTD | PMID:18445702 |
| selenium atom | decreases expression | ISO | RGD:1318484 | 6480464 | Selenium results in decreased expression of SLC19A2 mRNA | CTD | PMID:19244175 |
| tert-butyl hydroperoxide | increases expression | ISO | RGD:1318484 | 6480464 | tert-Butylhydroperoxide results in increased expression of SLC19A2 mRNA | CTD | PMID:15336504 |
| tetrachloromethane | affects expression | ISO | RGD:1318485 | 6480464 | Carbon Tetrachloride affects the expression of SLC19A2 mRNA | CTD | PMID:17484886 |
| thiamine(1+) chloride | increases uptake | ISO | RGD:1318484 | 6480464 | SLC19A2 protein results in increased uptake of Thiamine | CTD | PMID:16705148 |
| thiamine(1+) chloride | increases expression | ISO | RGD:1318484 | 6480464 | Thiamine deficiency results in increased expression of SLC19A2 protein; more ... | CTD | PMID:16705148 |
| tioguanine | decreases expression | EXP | | 6480464 | Thioguanine results in decreased expression of SLC19A2 mRNA | CTD | PMID:16005536 |
| valproic acid | multiple interactions | ISO | RGD:1318484 | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of SLC19A2 mRNA | CTD | PMID:17183730 |
| valproic acid | affects expression | ISO | RGD:1318485 | 6480464 | Valproic Acid affects the expression of SLC19A2 mRNA | CTD | PMID:17292431 |